TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

  title={TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.},
  author={Ellen FM 't Hoen},
  journal={Chicago Journal of International Law},
  • E. Hoen
  • Published 2002
  • Medicine, Political Science
  • Chicago Journal of International Law
I. INTRODUCTION Infectious diseases kill over 10 million people each year, more than 90 percent of whom are in the developing world.1 The leading causes of illness and death in Africa, Asia, and South America-regions that account for four-fifths of the world's population-are HIV/AIDS, respiratory infections, malaria, and tuberculosis. In particular, the magnitude of the AIDS crisis has drawn attention to the fact that millions of people in the developing world do not have access to the… 

Patents, Access to Medicines and the Role of Non-Governmental Organisations

  • N. Ford
  • Political Science, Medicine
  • 2004
Experience from South Africa, Thailand, Kenya and Guatemala shows the enormous pressures countries face in implementing the TRIPS Agreement in a manner that protects public health and underscores the vital role played by civil society in defending the right to access affordable medicines.

Access to essential medicines in East Africa: A review of East Africa community and its member states approach to WTO-TRIPS public health flexibilities

The fulfilment of the obligations under TRIPS has generated a lot of controversy especially as they have been seen as the cause of reduced access to essential medicines in developing countries.

Patent right and access to medicine

  • C. Cao
  • Political Science, Medicine
  • 2011
This thesis lay out the conflicts between patent right protection and access to medicine as human right, especially the impact of TRIPS Agreement on the availability and prices of drugs in developing countries.

The G8 and access to medicines: no more broken promises

Challenges between Access to Medicine and Pharmaceutical Patents

The aim of this research is a study of Challenges between Access to Medicine and Pharmaceutical Patents and offering solutions applied to make balance between these rights.

Access to Medicines and Medical Equipment during COVID-19: Searching Compatibility between the WTO and the WHO

Affordable access to medicines is a key determinant of a country’s resilience to health crises. The modern hyper-connected international trade and production networks have a vital role to play in

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.

The need for scaling-up is as urgent as ever: over two-thirds of the six million people in the developing world who are in urgent need of ARV therapy live in sub-Saharan Africa but less than 2% of these have access to this treatment.

TRIPS and Public Health

This paper outlines the events leading up to the Doha Declaration and examines whether or not the declaration provides for sufficient flexibility to fulfill the public health needs of all WTO member countries.

Intellectual Property, Access to Medicines, and Health: New Research Horizons

In this introduction, we review the literature on intellectual property rights and access to medicines, identifying two distinct generations of research. The first generation analyzes the origins of

Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.

The potential threats posed by trade agreements vis-à-vis efforts to provide universal access to antiretroviral medications are critically examined and the conditioning of economic development upon the strengthening of intellectual property law demands careful attention when public health is at stake.